EVOTF·D1646D105·US·equity·Healthcare - Drug Manufacturers - Specialty & Generic-Activist
EVOTF (Evotec SE) is held by 0 institutional investors as of Q3 2022.
See how EVOTF's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer